ARCHIVES

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 20 | May 22, 2009

Download PDF Visit The Full Archive

Related Articles

Survivorship Research RFA To Be Reissued; Biomedical Imaging Institute Names 10 to Advisory Council

November 29, 2002

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

March 1, 1996

In Brief: Middle East Cancer Consortium Formed; Armitage, Mayer Elected To ASCO Positions

May 24, 1996

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

White Heads NIH Legislative Policy Office

March 5, 2010

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010